G&E Herbal Biotechnology Co., Ltd. (TPEX: 4911)

G&E Herbal Biotechnology Revenue

G&E Herbal Biotechnology had revenue of 59.56M TWD in the quarter ending June 30, 2024, with 33.87% growth. This brings the company's revenue in the last twelve months to 211.15M, up 56.45% year-over-year. In the year 2023, G&E Herbal Biotechnology had annual revenue of 181.44M with 180.84% growth.

• Revenue (ttm): 211.15M
• Revenue Growth: +56.45%
• P/S Ratio: 15.40
• Revenue / Employee: 5.71M
• Employees: 37
• Market Cap: 3.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	181.44M	116.84M	180.84%
Dec 31, 2022	64.61M	40.04M	162.94%
Dec 31, 2021	24.57M	-3.66M	-12.96%
Dec 31, 2020	28.23M	10.68M	60.82%
Dec 31, 2019	17.55M	15.35M	697.91%